When cardiotoxicity demonstrated in Cardio-oncology is investigated in other contexts: Research into the cardiovascular effects of antiangiogenic drugs used in ophthalmology

When cardiotoxicity demonstrated in Cardio-oncology is investigated in other contexts: Research into the cardiovascular effects of antiangiogenic drugs used in ophthalmology

Saved in:

Bibliographic Details
Main Author:	Júlia Cristina Toste
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Revista Portuguesa de Cardiologia
Online Access:	http://www.sciencedirect.com/science/article/pii/S0870255124003263
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients
by: Alessandra Cuomo, et al.
Published: (2022-06-01)

Another Perspective on Cardio-Oncology: Insights from Houston, Texas
by: Ynalvez Leslie A., et al.
Published: (2024-12-01)

Effects of described demonstrator ability on brain and behavior when learning from others
by: Ida Selbing, et al.
Published: (2025-01-01)

From Global Insights to National Impact: Advancing Cardio-Oncology in Iraq
by: Mustafa H. Ajlan, et al.
Published: (2024-12-01)

A minimalist cardio-oncology service: A personal experience from Wales
by: Riaz Muhammad Hamza, et al.
Published: (2024-11-01)

Nursing knowledge in cardio-oncology: results of an international learning needs-assessment survey
by: Anecita Fadol, et al.
Published: (2025-01-01)

CardioVilla 2011: congratulations to the health of cardiovascular medicine in Cuba
by: Raúl Dueñas Fernández, et al.
Published: (2011-11-01)

Local factors determining the response to antiangiogenic therapy with first-line drugs in macular neovascularization
by: V.G. Likhvantseva, et al.
Published: (2024-06-01)

Modulation of Immunity by Antiangiogenic Molecules in Cancer
by: Magali Terme, et al.
Published: (2012-01-01)

Disrupted Balance of Angiogenic and Antiangiogenic Signalings in Preeclampsia
by: Mitsuko Furuya, et al.
Published: (2011-01-01)

Long-term cardiac MRI follow up of MANTICORE (Multidisciplinary Approach to Novel Therapies in Cardio-Oncology REsearch)
by: Dina Labib, et al.
Published: (2025-02-01)

Assessment of cardio-oncology knowledge and practice among healthcare providers in Saudi Arabia: a comprehensive nationwide survey
by: Hisham A. Badreldin, et al.
Published: (2024-12-01)

Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01)

Investigation of cardiotoxic effects of marbofloxacin
by: Devran Coşkun, et al.

Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigationResearch in context
by: Karl Michaëlsson, et al.
Published: (2025-03-01)

Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs
by: Xiang Zhang, et al.
Published: (2025-02-01)

Multimodal Imaging in Ophthalmology
by: Lisa Toto, et al.
Published: (2016-01-01)

Does Adiponectin Act as an Antiangiogenic Factor in B-Cell Chronic Lymphocytic Leukemia?
by: Stefano Molica, et al.
Published: (2009-01-01)

New approach to modeling of antiangiogenic treatment on the basis of Hahnfeldt et al. model
by: Jan Poleszczuk, et al.
Published: (2011-03-01)

Proapoptotic and Antiangiogenic Activities of Arctium Lappa L. on Breast Cancer Cell Lines
by: Mohamad Taleb Agha, et al.
Published: (2020-01-01)

Naxos Disease and Related Cardio-Cutaneous Syndromes
by: Alexandros Protonotarios, MD, et al.
Published: (2025-02-01)

When molecular biology transforms clinical oncology: the EGFR journey in colorectal cancer
by: Pietro Paolo Vitiello, et al.
Published: (2025-02-01)

Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
by: Qiaolin Huang, et al.
Published: (2025-02-01)

Rare Presentation of Cardiotoxicity Related to 5-Fluorouracil
by: Mariam Charkviani, et al.
Published: (2020-01-01)

Cytotoxicity and Antiangiogenic Activity of Turbinaria ornata Agardh and Padina australis Hauck Ethanolic Extracts
by: Jenefa L. Canoy, et al.
Published: (2018-01-01)

Saunders Ophthalmology Word Book /
by: Adams, Joyce
Published: (1991)

Pediatric ophthalmology for Primary Care /
Published: (2003)

Perspectives of proteomic analysis in ophthalmology
by: A.A. Krylova, et al.
Published: (2023-11-01)

Povidone-iodine in ophthalmological practice
by: I.A. Koroleva, et al.
Published: (2018-07-01)

Optical Coherence Tomography in Ophthalmology
by: Eduardo Buchele Rodrigues, et al.
Published: (2012-01-01)

Cardiovascular Drug Therapy /
by: Messerli, Franz H.
Published: (1990)

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Pigment Epithelium-Derived Factor-Loaded PEGylated Nanoparticles as a New Antiangiogenic Therapy for Neovascularization
by: Feng Zhao, et al.
Published: (2022-01-01)

Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway
by: Nazir Nausheen, et al.
Published: (2025-01-01)

Review of ophthalmology undergraduate teaching curriculum
by: Sivanthi Kanagasundaram
Published: (2025-01-01)

Amiodarone Pulmonary, Neuromuscular and Ophthalmologic Toxicity
by: Karen EA Burns, et al.
Published: (2000-01-01)

Examination of common culture medium for human hepatocytes and engineered heart tissue: Towards an evaluation of cardiotoxicity associated with hepatic drug metabolism in vitro.
by: Shinichiro Horiuchi, et al.
Published: (2024-01-01)

Evaluation of antidiabetic potential, cardio, pancreatic, nephroprotective effect, and herb-herb-drug interaction of Madhukiran formulations in T2 diabetic rats
by: Vrushabh S. Kondalkar, et al.
Published: (2025-05-01)

Review of Cardiotoxicity in Pediatric Cancer Patients: During and after Therapy
by: Joy M. Fulbright
Published: (2011-01-01)